Tagged with

Switzerland With 35 years’ experience in natural extracts, purified ingredients, semi-synthetic APIs of natural origin and manufacturing products to the highest standards of excellence and quality, Linnea is a ground-breaking company with a strong heritage that successfully accepts challenges in new segments while expanding its product portfolio. What changes in attitudes…

Taiwan Chuan-Der Huang, founder, president, and CEO of KriSan Biotech, a recently established Taiwan-based service provider focused on new drug process and analytical R&D for small molecules and peptides from Pre-clinical (IND) to Phase II clinical trial, provides insights into the company’s unique positioning in Taiwan’s new drug development value chain,…

Greece Outspoken, charismatic and dedicated General Manager of Pierre-Fabre Greece, Philippe Lambrinos, shares his insights on the company’s presence and performance in the challenging Greek market, how it’s manoeuvring issues of market access and clawbacks, as well as his overarching vision for Pierre-Fabre in Greece. Mr. Lambrinos, you have spent 21…

Mexico Martin Ferrari del Sel, country manager at Dräger Mexico, explains the importance of enhancing the efficiency ratios in public and private hospitals, considering the shortage of health infrastructure to cover the needs of Mexican patients, and showcases the added value of Dräger’s offering to help the entire national healthcare system…

Greece As the trusted source of premier market intelligence, IMS stands as a formidable force that many companies rely on for guidance through the unpredictable Greek pharmaceutical landscape. General Manager Nikolaos Kostaras proudly speaks about spearheading the affiliate through many transformative changes, defining its core proficiencies and looking to the future…

Ireland Philip Martin, founder and CEO of Cora Systems in Ireland, explains why his company is ideally positioned to help the pharmaceutical industry increase efficiency and save costs through their agile, flexible and intuitive project management software solutions. “Along with tech improvements, incredible new complexity in how the industry operates has…

Mexico Armando Martínez, general manager at Beckman Coulter Mexico, explains the company’s unique business model Coulter, the strong added-value of its broad and innovative healthcare solutions, and how they help improve the efficiency of laboratories. Could you please introduce yourself to our international audience as well as the operations of Beckman…

Greece Spearheading one of the top-ranked multinational pharmaceutical companies in Greece, Marcos Gerassopoulos, Country Chair of Sanofi, shares his views on how global Sanofi transformations are translated in Greece, the challenges in the pharmaceutical landscape in the country, and Greek resiliency in the midst of a crisis.  Mr. Gerassopoulos, you have…

Switzerland Working at the convergence of information technology and operational technology, Rockwell helps clients to unlock value by giving them the right data to make smart decisions. For the life science industry in particular, there are many unexplored opportunities to unlock value within supply chains. The buzzword in automation is Industry…

Greece Starting as a one-man-show when he began the Greek affiliate in 2009, Orion Pharma’s General Manager, Thanassis Panopoulos discusses the company’s high level of resiliency, the challenges of bringing a Finnish company to Greece, communicating the value of their life-saving products to relevant stakeholders, as well as their objective to…

Taiwan Vivian Lee, president and CEO of Linical Taiwan, documents the affiliate’s main milestones since its establishment in 2013, its strategic positioning among the Linical Group as a regional hub, as well as the crucial role Linical Taiwan aims to play in further propelling the impressive growth of Taiwan’s R&D-driven biopharmaceutical…

Switzerland Working to stay ahead in the highly competitive medical device field, Boston Scientific’s Philippe Hügli launched a Customer Insight Initiative in Switzerland which has served as a pilot for the European organization.  Considering the immense competition in the medical device industry today, what do you see as the key trends…